Trevarx Biomedical, Inc. — Form D
Trevarx Biomedical, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-04. The offering totals $750K, of which $350K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-08-04
- Form: D
- Accession: 0001783904-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $350K
- Remaining: $400K
- Investors: 6
- Date of first sale: 2025-07-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-553569
Issuer
- Name: Trevarx Biomedical, Inc.
- CIK: 0001783904
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2929 ARCH STREET, 3RD FLOOR, PHILADELPHIA, PA, 19104
- Phone: (206) 949-4956
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Jean Cho | Director | Philadelphia, PA |
| Jean Cho | Executive Officer | Philadelphia, PA |
Other filings by this issuer (2)
More